Cargando…
Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma
Cancer stem cells are thought to be the main drivers of tumorigenesis for malignancies such as glioblastoma (GBM). They are maintained through a close relationship with the tumor vasculature. Previous literature has well-characterized the components and signaling pathways for maintenance of this ste...
Autores principales: | Akindona, Funto A., Frederico, Stephen C., Hancock, John C., Gilbert, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454306/ https://www.ncbi.nlm.nih.gov/pubmed/36091174 http://dx.doi.org/10.3389/fonc.2022.947634 |
Ejemplares similares
-
Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
por: Jain, Saket, et al.
Publicado: (2022) -
Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma
por: Frederico, Stephen C., et al.
Publicado: (2021) -
Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
por: Bastos, António G. P., et al.
Publicado: (2022) -
Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma
por: Zhang, Ashley B., et al.
Publicado: (2023) -
Glioblastoma Distance From the Subventricular Neural Stem Cell Niche Does Not Correlate With Survival
por: Mistry, Akshitkumar M., et al.
Publicado: (2020)